CustomArray Revenue and Competitors
Estimated Revenue & Valuation
- CustomArray's estimated annual revenue is currently $1.7M per year.
- CustomArray's estimated revenue per employee is $155,000
Employee Data
- CustomArray has 11 Employees.
- CustomArray grew their employee count by -8% last year.
CustomArray's People
Name | Title | Email/Phone |
---|---|---|
1 | Research Scientist | Reveal Email/Phone |
2 | Engineering/Manufacturing Technician | Reveal Email/Phone |
3 | Research Scientist | Reveal Email/Phone |
CustomArray Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is CustomArray?
CustomArray, Inc. is a company dedicated to providing products and services to the "Omics" marketplace. CustomArray can provide instruments such as the B3â„¢ Synthesizer that uses semiconductor arrays to rapidly synthesize DNA arrays “on chipâ€. Arrays can be synthesized automatically on the instrument using either the 4x2kâ„¢, 12kâ„¢, or 90kâ„¢ array chips. In situ synthesis on up to 32 arrays (for 4x2k format) or 8 arrays (for other formats) can be performed in under 24 hours. We can also provide pre-made arrays ready for your experiment, and arrays can be read either using standard fluorescence chip readers (one-color or two-color readouts) or can be read using electrochemical detection on our ElectraSense reader. CustomArray also offers extensive services using our platforms to measure gene expression, to measure microRNA expression, to identify aptamer sequences (DNA sequences that bind with high affinity to customer-provided proteins), to identify potent siRNA sequences against select targets in vitro and validate the function of these targets both in vitro and in vivo, to provide large pools of oligos for specific applications such as sequencing, as well as other services. More information on products and services is in the "products" section of the website. We look forward to continuing to supply essential products to previous customers and welcome new customers to explore the advantages of our technologies and services.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | 0% | N/A |
#2 | $0.4M | 11 | 0% | $21.5M |
#3 | $1M | 11 | 0% | N/A |
#4 | $1M | 11 | N/A | N/A |
#5 | $1M | 11 | N/A | N/A |